Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo- controlled trial

Neurology

Volumn 43, Issue 4 I, 1993, Pages 655-661

  Duquette, P ^a   Girard, M ^a   Despault, L ^a   DuBois, R ^a   Knobler, R L ^a   Lublin, F D ^a   Kelley, L ^a   Francis, G S ^a   Lapierre, Y ^a   Antel, J ^a   Freedman, M ^a   Hum, S ^a   Greenstein, J I ^a   Mishra, B ^a   Muldoon, J ^a   Whitaker, J N ^a   Evans, B K ^a   Layton, B ^a   Sibley, W A ^a  

^a University Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; FEMALE; FEVER; HUMAN; IMMUNE SYSTEM; INJECTION PAIN; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION; SUICIDE ATTEMPT;

EID: 0027418515     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.43.4.655     Document Type: Article

References (0)